The effect of glycemic control with basal-bolus insulin therapy under short term hospitalization on chylomicron metabolism

The effect of glycemic control with basal-bolus insulin therapy under short term hospitalization on chylomicron metabolism - The effect of basal-bolus insulin therapy on chylomicron metabolism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026950

Enrollment

Registered

2017-04-11

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

basal bolus insulin therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients who agree to hospitalization for diabetic control

Exclusion criteria

Exclusion criteria: Treated with insulin have a history or evidence of severe liver disease severe renal disease endocrine disease carcinoma

Design outcomes

Primary

Measure	Time frame
The difference of the daily profile of serum lipids and the particle size of chylomicron between before and after glycemic control.	—

Countries

Japan

Contacts

Public ContactFumitaka Okajima

Nippon Medical School, Chiba-Hokusoh Hospital Division of Endocrinology, Department of Medicine

okaji@nms.ac.jp0476-99-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026